BerriQi

BerriQi® is a patented nutraceutical ingredient crafted from freeze-dried New Zealand boysenberries and apples, delivering a concentrated source of polyphenols, notably anthocyanins, ellagic acid, and quercetin, alongside fiber and vitamin C. These bioactives exhibit strong antioxidant and anti-inflammatory properties, targeting respiratory immune balance. BerriQi modulates macrophage activity, shifting from the pro-inflammatory M1 phenotype to the reparative M2 phenotype, which aids in resolving airway inflammation, reducing mucus overproduction, and promoting tissue repair. Preclinical and clinical studies show significant outcomes: ↓35% airway inflammation, ↑ antioxidant enzyme activity, and improved lung resilience against pollutants and allergens. Its dual-fruit synergy amplifies bioactivity, making BerriQi a science-backed solution for respiratory health and immune modulation.